ES432106A1 - Procedimiento para la preparacion de d-homo-20-cetopregna- nos. - Google Patents

Procedimiento para la preparacion de d-homo-20-cetopregna- nos.

Info

Publication number
ES432106A1
ES432106A1 ES432106A ES432106A ES432106A1 ES 432106 A1 ES432106 A1 ES 432106A1 ES 432106 A ES432106 A ES 432106A ES 432106 A ES432106 A ES 432106A ES 432106 A1 ES432106 A1 ES 432106A1
Authority
ES
Spain
Prior art keywords
hydrogen
carbon
see formula
ketopregnanes
homo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES432106A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES432106A1 publication Critical patent/ES432106A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
ES432106A 1973-11-30 1974-11-20 Procedimiento para la preparacion de d-homo-20-cetopregna- nos. Expired ES432106A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
ES432106A1 true ES432106A1 (es) 1976-11-01

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
ES432106A Expired ES432106A1 (es) 1973-11-30 1974-11-20 Procedimiento para la preparacion de d-homo-20-cetopregna- nos.

Country Status (14)

Country Link
US (1) US4045574A (enExample)
JP (1) JPS5084561A (enExample)
AT (1) AT347611B (enExample)
CA (1) CA1030522A (enExample)
CH (1) CH618183A5 (enExample)
DD (1) DD115659A5 (enExample)
DK (1) DK134348C (enExample)
ES (1) ES432106A1 (enExample)
FR (1) FR2253512B1 (enExample)
GB (1) GB1494097A (enExample)
IE (1) IE40423B1 (enExample)
IL (1) IL46153A (enExample)
NL (1) NL7415577A (enExample)
SE (1) SE408426B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
DE60308388T2 (de) * 2002-08-16 2007-09-20 Pharmacia & Upjohn Co. Llc, Kalamazoo 5-Androsten-3beta-ol-Steroide und Verfahren für ihre Herstellung
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
US9365611B2 (en) 2013-04-17 2016-06-14 Sage Therapeutics, Inc. 19-NOR neuroactive steroids and methods of use thereof
KR20230172622A (ko) 2013-04-17 2023-12-22 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PT3488852T (pt) 2013-08-23 2021-02-03 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
BR112017007902B1 (pt) 2014-10-16 2023-12-05 Sage Therapeutics, Inc Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central
HUE051488T2 (hu) 2014-10-16 2021-03-01 Sage Therapeutics Inc Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3481844B1 (en) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
JP7049313B2 (ja) 2016-07-11 2022-04-06 セージ セラピューティクス, インコーポレイテッド C17、c20、およびc21置換神経刺激性ステロイドおよびそれらの使用方法
WO2019126761A1 (en) * 2017-12-22 2019-06-27 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
BR112021010996A2 (pt) 2018-12-05 2021-08-31 Sage Therapeutics, Inc. Esteroides neuroativos e seus métodos de uso
CA3125675A1 (en) 2019-01-08 2020-07-16 Chengdu kanghong pharmaceutical co ltd Steroid compounds, uses and process for preparation therefor
BR112021024033A2 (pt) 2019-05-31 2022-02-08 Sage Therapeutics Inc Esteroides neuroativos e suas composições
US20230085354A1 (en) * 2019-06-27 2023-03-16 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3990468A1 (en) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Compounds for treating cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
CA1030522A (en) 1978-05-02
NL7415577A (nl) 1975-06-03
FR2253512A1 (enExample) 1975-07-04
IE40423B1 (en) 1979-05-23
JPS5084561A (enExample) 1975-07-08
CH618183A5 (enExample) 1980-07-15
SE408426B (sv) 1979-06-11
DD115659A5 (enExample) 1975-10-12
DK134348C (da) 1977-03-21
FR2253512B1 (enExample) 1978-02-03
GB1494097A (en) 1977-12-07
AU7586774A (en) 1976-06-03
SE7414960L (enExample) 1975-06-02
DK604174A (enExample) 1975-07-28
DK134348B (da) 1976-10-25
IL46153A (en) 1979-01-31
IL46153A0 (en) 1975-02-10
ATA950774A (de) 1978-05-15
IE40423L (en) 1975-05-30
US4045574A (en) 1977-08-30
AT347611B (de) 1979-01-10

Similar Documents

Publication Publication Date Title
ES432106A1 (es) Procedimiento para la preparacion de d-homo-20-cetopregna- nos.
ES439720A1 (es) Procedimiento para la preparacion de 18-metil-19-nor-20-ce- topregnanos.
ES366943A1 (es) Procedimiento para la preparacion de derivados de 1-etil-3,3-dimetil-ciclohexano.
ES398036A1 (es) Procedimiento para la obtencion de derivados del acido 2- fosfono-butano-1,2-dicarboxilico.
GB1454489A (en) Paromomycin derivatives
ES420630A1 (es) Procedimiento para la preparacion de n-(furil-metil)-morfi-nanos.
ES441784A1 (es) Procedimiento para la preparacion de 7-hidroxi-estradioles.
ES402608A1 (es) Procedimiento para el desdoblamiento de racematos de d, 1- fenilpropanolamina con acidos opticamente activos.
ES432479A1 (es) Procedimiento para la preparacion de esteres dialcohilicos de acido malonico.
ES427869A1 (es) Procedimiento para la preparacion de esteres alcoholicos deacido 5-fenilsulfinil-2-bencimidazol-carbamico.
ES412799A1 (es) Un procedimiento para preparar alcoholes alcohilsulfonilme-tilbencilicos.
ES274909A1 (es) Procedimiento para la preparaciën de nuevos derivados de iminodibencilo
ES478433A1 (es) Procedimiento para la obtencion de 13-oxabiciclo 10,3,0-pen-tadecano.
ES428228A1 (es) Procedimiento para la preparacion de 8alfa-estratrienos.
ES425430A1 (es) Procedimiento para la preparacion de derivados de biciclo- alcano.
ES406542A1 (es) Procedimiento para la preparacion de nuevos cardenolidgli- cosidos.
ES368164A1 (es) Procedimiento para la obtencion de 21- aldehidos de la se- rie pregnano y de sus derivados.
ES446837A1 (es) Procedimiento para la preparacion de sales de ester dimeti- laminoetilico de acido para-clorofenoxiacetico.
GB991474A (en) Novel steroid compounds and their preparation
ES422248A1 (es) Procedimiento para la preparacion de 7-cloro-1,2-dihidro-5-fenil - 1,4-benzodiazepin-2-onas.
ES423976A1 (es) Procedimiento para la preparacion de nuevas bencilaminas.
ES316644A1 (es) Metodo para formar un derivado con contenido de oxigeno de un compuesto insaturado.
ES390920A1 (es) Procedimiento para la preparacion de 4,5 alfa - oxido - gufa-20,22-dienolid-3-(ramnosido 2'83' - dialcohilortocarbo-natos).
ES446110A1 (es) Procedimiento para la preparacion de 10alfa, 11alfa-metilen-prostaglandinas.
ES422876A1 (es) Procedimiento para la obtencion de derivados del acido prostanico.